Author: Kristin Samuelson

Northwestern and the American Lung Association have begun a first-of-its-kind longitudinal study to track and analyze the lungs of millennials at the peak of their lung health.

The Department of Medicine’s Division of General Internal Medicine and Geriatrics officially become two divisions: the Division of Geriatrics and the Division of General Internal Medicine.

Northwestern Medicine scientists have discovered a master gene that programs ear hair cells’ development, overcoming a major hurdle towards restoring hearing.

The Michael J. Fox Foundation for Parkinson’s Research has chosen Northwestern to receive an Edmond J. Safra Fellowship in Movement Disorders to train a movement disorder clinician-investigator.

A new Northwestern Medicine study has found almost half of U.S. adults with heart failure have poorly controlled hypertension and diabetes.

Tameka Brannon, previously senior program administrator for the Northwestern University Center for Outcomes Research and Education, has been named director of Feinberg’s Office of Diversity and Inclusion.

On April 7 and 8, more than 200 prospective medical students visited Feinberg for a “Second Look” at the medical school. The two-day event allowed admitted students to get a feel for life at Feinberg by attending seminars, touring campus and meeting with current students and faculty.

Northwestern Medicine investigators have discovered a novel signaling pathway activated by interferons, a group of immune system proteins, that suppresses the anti-tumor response of interferons in patients with a particular type of blood cancer, according to findings published in Nature Communications. Leonidas Platanias, MD, PhD, the Jesse, Sara, Andrew, Abigail, Benjamin and Elizabeth Lurie Professor of Oncology, director of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, was the senior author of the study published in Nature Communications. Targeting this pathway in combination with interferon therapy may provide a novel approach to improving therapy response and overall patient…

Jeremy Nathans, MD, PhD, an investigator of the Howard Hughes Medical Institute and a professor at Johns Hopkins University School of Medicine, known for his landmark discoveries into the molecular mechanisms of visual system development, function and disease, is the recipient of the 2022 Mechthild Esser Nemmers Prize in Medical Science at Northwestern University.

New advances in CRISPR gene-editing technology may lead to longer-lasting treatments and new therapeutic strategies for HIV/AIDS.